title: Lysoplasmenylcholine increases neutrophil adherence to human coronary artery endothelial cells.
abstract: We demonstrated previously that thrombin stimulation of human coronary artery endothelial cells (HCAEC) results in release of choline lysophospholipids [lysophosphatidylcholine (lysoPtdCho) and lysoplasmenylcholine (lysoPlsCho)]. These amphiphilic metabolites have been implicated in arrhythmogenesis following the onset of myocardial ischemia, but studies examining their direct effects on the vasculature remain limited. We and others have shown that thrombin and lysoPtdCho can increase cell surface adhesion molecules and adherence of circulating inflammatory cells to the endothelium. This study supports our hypothesis that these changes may be mediated, at least in part, by lysoPlsCho, thus implicating this metabolite as an inflammatory mediator in the coronary vasculature and a modulator of the progression of atherosclerosis. Apical stimulation of HCAEC with thrombin resulted in the production and release of choline lysophospholipids from the apical surface of the HCAEC monolayer. Basolateral stimulation had no effect on choline lysophospholipid production or release from either the apical or basolateral surface of the HCAEC monolayer. Incubation of HCAEC with lysoPlsCho or lysoPtdCho resulted in similar increases in HCAEC surface expression of P-selectin and E-selectin. Furthermore, lysoPlsCho increased cell surface expression of P-selectin, E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 with a time course similar to that of thrombin stimulation. Increased presence of cell surface adhesion molecules may contribute to the significant increase in adherence of neutrophils to either thrombin- or lysoPlsCho-stimulated HCAEC. These results demonstrate that the presence of thrombin at sites of vascular injury in the coronary circulation, resulting in increased choline lysophospholipid release from the HCAEC apical surface, has the potential to propagate vascular inflammation by upregulation of adhesion molecules and recruitment of circulating inflammatory cells to the endothelium.
authors.affiliation: Department of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri 63104, USA.
authors.forename: Maureen C
authors.initials: MC
authors.lastname: White
authors.forename: Prerna
authors.initials: P
authors.lastname: Rastogi
authors.forename: Jane
authors.initials: J
authors.lastname: McHowat
mesh_terms: D002448:Cell Adhesion; D002478:Cells, Cultured; D003324:Coronary Artery Disease / Q000378:metabolism; D003331:Coronary Vessels / Q000166:cytology / Q000378:metabolism*; D019040:E-Selectin / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D008244:Lysophosphatidylcholines / Q000378:metabolism; D008246:Lysophospholipids / Q000378:metabolism*; D009504:Neutrophils / Q000378:metabolism*; D019007:P-Selectin / Q000378:metabolism; D013917:Thrombin / Q000378:metabolism*; D013997:Time Factors; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
chemical_list: D019040:E-Selectin; D018836:Inflammation Mediators; D008244:Lysophosphatidylcholines; D008246:Lysophospholipids; D019007:P-Selectin; D019010:Vascular Cell Adhesion Molecule-1; C021215:lysoplasmalogens; D018799:Intercellular Adhesion Molecule-1; D013917:Thrombin